Evidence map›Paper›PMID 25663903›Full record

ArticleOncology letters2015

Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies.

Xiaoyi Zhang, Guiqin Zhou, Bo Sun, Guohua Zhao, Dezhong Liu, Jiage Sun, Chuanhai Liu, Hui Guo

Abstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2016
    Pooled it
  7. Trial
  8. Arsenic in Drinking Water and Prostate Cancer: A Population-Based Case-Control Study in Northern Chile.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  9. Betulinic acid and obesity-related disorders.Frontiers in pharmacology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Mechanism and recent updates on insulin-related disorders.World journal of clinical cases · 2023
    Review
  16. The Role of BMI in Allostatic Load and Risk of Cancer Death.American journal of preventive medicine · 2023
    Article
  17. Review
  18. Neighborhood Obesogenic Environment and Risk of Prostate Cancer: The Multiethnic Cohort.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoyi ZhangDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Guiqin ZhouCenter of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing 100088, P.R. China.
Bo SunDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Guohua ZhaoDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Dezhong LiuDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Jiage SunDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Chuanhai LiuDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.
Hui GuoDepartment of Urology, The Second Artillery General Hospital People's Liberation Army, Beijing 100088, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of epidemiological studies have suggested that obesity is associated, albeit inconsistently, with the incidence of prostate cancer (PCa). In order to provide a quantitative assessment of this association, the present study examined the correlation between obesity and the incidence and associated mortalities of PCa in an updated meta-analysis of cohort studies. The cohort studies were identified by searching the EMBASE and MEDLINE databases on January 1, 2014. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. In total, 17 studies, which included 3,569,926 individuals overall, were selected according to predefined inclusion criteria. Based upon the results of the random-effects models, obesity was not significantly correlated with the incidence of PCa (RR, 1.00; 95% CI, 0.95-1.06). However, further analysis revealed that obesity was significantly correlated with an increased risk of aggressive PCa (RR, 1.14; 95% CI, 1.04-1.25). Furthermore, an increased risk of PCa-associated mortality was significantly associated with obesity (RR, 1.24; 95% CI, 1.15-2.33), without any heterogeneity between the studies (I

Indexed as

incidencemeta-analysismortalityobesityprospective cohort studiesprostate cancer

Identifiers

PMID25663903
PMCPMC4315023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.